Hikma Pharmaceuticals Plc Director/PDMR Shareholding (5272E)

TIDMHIK

RNS Number : 5272E

Hikma Pharmaceuticals Plc

28 February 2020

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Release of a pledge by Darhold Limited over 
       transaction               1,000,000 Ordinary Shares of 10 pence each in 
                                 Hikma Pharmaceuticals PLC in favour of Bank 
                                 J. Safra Sarasin. The Executive Chairman is 
                                 a director of and shareholder in Darhold Limited 
                                 with an equity interest of 21.99%. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,000,000 
 d)   Aggregated information    Aggregated volume: 1,000,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   28 February 2020 
 f)   Place of the              Amman 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Release of a pledge by Darhold Limited over 
       transaction               1,000,000 Ordinary Shares of 10 pence each in 
                                 Hikma Pharmaceuticals PLC in favour of Bank 
                                 J. Safra Sarasin. The Executive Vice Chairman 
                                 is a director of and shareholder in Darhold 
                                 Limited with an equity interest of 11.08%. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,000,000 
 d)   Aggregated information    Aggregated volume: 1,000,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   28 February 2020 
 f)   Place of the              Amman 
       transaction 
 

Mohammed 'Ali' Al-Husry

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mohammed 'Ali' Al-Husry 
 2    Reason for the notification 
 a)   Position/status           Non-Executive Director 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             ID Code: GB00B0LCW083 
       instrument, type 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Release of a pledge by Darhold Limited over 
       transaction               1,000,000 Ordinary Shares of 10 pence each in 
                                 Hikma Pharmaceuticals PLC in favour of Bank 
                                 J. Safra Sarasin. The Non-Executive Director 
                                 is a director of and shareholder in Darhold 
                                 Limited with an equity interest of 8.13%. 
 c)   Price(s) and              Price(s): GBP0.00p 
       volume(s)                 Volume(s): 1,000,000 
 d)   Aggregated information    Aggregated volume: 1,000,000 
                                 Price: GBP0.00p 
 e)   Date of the transaction   28 February 2020 
 f)   Place of the              Amman 
       transaction 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBDGDDXDDDGGI

(END) Dow Jones Newswires

February 28, 2020 07:26 ET (12:26 GMT)